NUV 569
Alternative Names: NUV-569Latest Information Update: 22 Jun 2022
At a glance
- Originator Nuvation Bio
- Class Antineoplastics
- Mechanism of Action WEE1 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Pancreatic cancer